Free Trial
NASDAQ:MDAI

Spectral AI (MDAI) Stock Price, News & Analysis

$1.87
+0.06 (+3.31%)
(As of 07/3/2024 ET)
Today's Range
$1.76
$1.87
50-Day Range
$1.55
$1.95
52-Week Range
$1.52
$19.50
Volume
171,650 shs
Average Volume
245,323 shs
Market Capitalization
$32.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Spectral AI MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
113.9% Upside
$4.00 Price Target
Short Interest
Healthy
5.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.56mentions of Spectral AI in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$10,320 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.33 out of 5 stars

Medical Sector

120th out of 896 stocks

Surgical & Medical Instruments Industry

20th out of 96 stocks

MDAI stock logo

About Spectral AI Stock (NASDAQ:MDAI)

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

MDAI Stock Price History

MDAI Stock News Headlines

Spectral AI adds two clinical trial sites to pivotal burn study
How did they achieve a perfect track record?
If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...
Spectral AI Joins Russell Microcap® Index
How to build a dividend portfolio…
Jack Carter just released a free presentation you don’t want to miss: How to Build a Dividend Portfolio with 3 Golden Rules These rules are critical if you want a rock solid, cash generating portfolio. Like this first one… Rule 1: Yield-to-Growth Ratio… And you’ll be able to learn all 3 golden rules for this type of portfolio during the presentation.
Spectral AI supports naked short selling probe
Spectral AI to join Russell Microcap Index
Spectral AI Set to Join Russell Microcap® Index
See More Headlines
Receive MDAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral AI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Today
7/05/2024
Next Earnings (Estimated)
8/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:MDAI
Fax
N/A
Employees
78
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+113.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-20,850,000.00
Pretax Margin
-135.94%

Debt

Sales & Book Value

Annual Sales
$18.06 million
Book Value
($0.10) per share

Miscellaneous

Free Float
7,564,000
Market Cap
$32.69 million
Optionable
Not Optionable
Beta
0.61
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Wensheng Fan (Age 54)
    Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO
    Comp: $978.63k
  • Mr. Vincent Stanley Capone (Age 57)
    CFO, General Counsel & Corporate Secretary
    Comp: $430.87k
  • Ms. Christine Marks
    Vice President of Marketing & Commercialization
  • Mr. Peter Martin Carlson CPA (Age 60)
    CEO & Director
  • Mr. Stan Micek
    Interim Chief Operating Officer
  • Dr. Jeffrey Thatcher Ph.D. (Age 40)
    Chief Scientist
    Comp: $259.72k
  • Dr. Jeffrey E. Carter F.A.C.S.
    M.D., Chief Medical Consultant
  • Mr. Erich L. Spangenberg (Age 62)
    CEO of its Health care & Director
    Comp: $37.02k
  • Prof. Paul Chadwick
    Executive Vice President of UK & EMEA
  • Mr. Jeremiah A. Sparks MBA
    Chief Commercialization Officer

MDAI Stock Analysis - Frequently Asked Questions

Should I buy or sell Spectral AI stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Spectral AI in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDAI shares.
View MDAI analyst ratings
or view top-rated stocks.

What is Spectral AI's stock price target for 2024?

1 equities research analysts have issued 12 month price objectives for Spectral AI's stock. Their MDAI share price targets range from $4.00 to $4.00. On average, they anticipate the company's stock price to reach $4.00 in the next year. This suggests a possible upside of 113.9% from the stock's current price.
View analysts price targets for MDAI
or view top-rated stocks among Wall Street analysts.

How have MDAI shares performed in 2024?

Spectral AI's stock was trading at $2.46 at the start of the year. Since then, MDAI stock has decreased by 24.0% and is now trading at $1.87.
View the best growth stocks for 2024 here
.

Are investors shorting Spectral AI?

Spectral AI saw a drop in short interest in June. As of June 15th, there was short interest totaling 394,500 shares, a drop of 17.7% from the May 31st total of 479,100 shares. Based on an average daily trading volume, of 288,200 shares, the days-to-cover ratio is currently 1.4 days. Currently, 5.4% of the shares of the stock are sold short.
View Spectral AI's Short Interest
.

When is Spectral AI's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our MDAI earnings forecast
.

How were Spectral AI's earnings last quarter?

Spectral AI, Inc. (NASDAQ:MDAI) released its quarterly earnings data on Tuesday, May, 7th. The company reported ($0.19) EPS for the quarter. The business had revenue of $6.33 million for the quarter.

What guidance has Spectral AI issued on next quarter's earnings?

Spectral AI issued an update on its FY 2024 earnings guidance on Friday, April, 19th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $28.0 million-$28.0 million, compared to the consensus revenue estimate of $28.1 million.

How do I buy shares of Spectral AI?

Shares of MDAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MDAI) was last updated on 7/5/2024 by MarketBeat.com Staff

From Our Partners